Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Senior VP and General Counsel | June 25, 2018 | June 27, 2018 |
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP, Chief Legal Officer & Sec | March 11, 2025 | March 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date June 25, 2018 · Filed June 27, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-06-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2018-06-25 · Exercise / conversion · Acquired 10,000 · Balance 10,000 Row 2 · 2018-06-25 · Sale · Disposed 8,444 · Balance 1,556 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Row 3 · 2018-06-25 · Sale · Disposed 1,556 · Balance 0 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $24.98 · Expires 2026-04-28 | Direct | 41,000 |
Reported balance
After 2018-06-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-06-25 · Exercise / conversion · Disposed 10,000 · Balance 41,000 F4: These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4: These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date March 11, 2025 · Filed March 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,020 |
Ending reported balance
After 2025-03-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-11 · Tax withholding · Disposed 1,538 · Balance 57,200 Row 2 · 2025-03-11 · Tax withholding · Disposed 1,180 · Balance 56,020 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2025 Filed Mar 13, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,180 | $23.95 | $28,261.00 |
DisclosureSEC source: 0000917520-25-000029 · wk-form4_1741897845.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,020 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,538 | $23.95 | $36,835.10 |
DisclosureSEC source: 0000917520-25-000029 · wk-form4_1741897845.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,200 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 773 | $22.61 | $17,477.53 |
DisclosureSEC source: 0000917520-25-000020 · wk-form4_1741724916.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,738 Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 21:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 4,070 | $24.60 | $100,101.65 |
DisclosureSEC source: 0000917520-24-000112 · wk-form4_1733347945.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,511 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 348 | $35.88 | $12,486.24 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · nonDerivative · entry 5 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,581 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,090 | $35.88 | $39,109.20 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · nonDerivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,929 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 17,890 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · derivative · entry 6 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,890 Underlying: Common Stock · 17,890 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,019 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 7,745 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,736 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,371 | $36.22 | $49,657.62 |
DisclosureSEC source: 0000917520-24-000034 · wk-form4_1710361689.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,991 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 799 | $36.73 | $29,347.27 |
DisclosureSEC source: 0000917520-24-000027 · wk-form4_1710278042.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,362 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000005 · wk-form4_1708638320.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,161 F1 · shares: On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | PurchaseCommon Stock | 2,640 | $37.89 | $100,035.14 |
DisclosureSEC source: 0001209191-23-034263 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,597 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of the purchase prices was $37.875 to $37.92. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 416 | $62.61 | $26,045.76 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 8 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,957 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 915 | $52.61 | $48,138.15 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 7 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,373 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 338 | $52.87 | $17,870.06 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 6 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,288 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 238 | $52.87 | $12,583.06 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 5 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,626 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 594 | $52.87 | $31,404.78 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,864 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,371 | $52.87 | $72,484.77 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,458 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,393 | $52.87 | $126,517.91 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,829 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,419 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · derivative · entry 9 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 Underlying: Common Stock · 12,419 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 5,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,222 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 5,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,152 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,511 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 560 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,111 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,551 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,488 | $65.11 | $96,883.68 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 8 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,395 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 691 | $65.11 | $44,991.01 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 7 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,883 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 286 | $65.11 | $18,621.46 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 6 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,574 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 404 | $65.11 | $26,304.44 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 5 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,860 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 349 | $65.11 | $22,723.39 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,264 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 873 | $65.11 | $56,841.03 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,613 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 218 | $65.11 | $14,193.98 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,486 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingNon-Qualified Stock Option (right to buy) · Derivative | 27,539 | $0.00 Strike: $65.11 | $0.00 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · derivative · entry 9 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,539 Underlying: Common Stock · 27,539 shares Expires 2030-03-11 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 9,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018842 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,704 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,712 | $66.32 | $113,539.84 |
DisclosureSEC source: 0001209191-22-015800 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,912 Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 22:02 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009389 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,624 F3 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 22:02 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009389 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,170 F2 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 22:02 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009389 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,605 F1 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 2,414 | $62.69 | $151,333.66 |
DisclosureSEC source: 0001209191-21-068109 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,085 Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 261 | $68.10 | $17,774.10 |
DisclosureSEC source: 0001209191-21-020776 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,499 Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 179 | $68.10 | $12,189.90 |
DisclosureSEC source: 0001209191-21-020776 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,760 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 7,267 | $0.00 Strike: $68.10 | $0.00 |
DisclosureSEC source: 0001209191-21-020776 · doc4.xml · derivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,267 Underlying: Common Stock · 7,267 shares Expires 2029-03-12 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/12/2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020776 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,939 Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 4,212 | $69.10 | $291,030.67 |
DisclosureSEC source: 0001209191-21-016835 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,528 Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 22:55 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,669 | $69.43 | $115,878.67 |
DisclosureSEC source: 0001209191-21-015363 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,740 Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:55 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 2,288 | $69.52 | $159,061.76 |
DisclosureSEC source: 0001209191-21-015363 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,409 Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,515 | $54.92 | $83,203.80 |
DisclosureSEC source: 0001209191-20-061790 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,697 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,390 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · derivative · entry 4 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,390 Underlying: Common Stock · 14,390 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 434 | $43.39 | $18,831.26 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,212 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.